Sanofi SA (ADR)  

(Public, NYSE:SNY)   Watch this stock  
Find more results for SNY
51.47
-0.09 (-0.17%)
Jul 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 51.11 - 51.52
52 week 46.95 - 54.64
Open 51.32
Vol / Avg. 0.00/929,869.00
Mkt cap 135.95B
P/E 26.85
Div/yield 1.91/3.71
EPS 1.92
Shares 1.32B
Beta 1.01
Inst. own 18%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 14.04% 11.53%
Operating margin 18.02% 15.33%
EBITD margin - 37.12%
Return on average assets - 3.91%
Return on average equity - 6.51%
Employees 112,128 -
CDP Score - 97 A-

Address

54 rue la Boetie
PARIS, 75008
France
+33-1-53774000 (Phone)
+33-1-53774463 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients� needs. Sanofi focuses on the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. As of February 2011, Sanofi portfolio comprised 55 projects in clinical development, of which 13 were in Phase III or had been submitted to the health authorities for approval. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. Effective March 5, 2014, Sanofi SA of France acquired an undisclosed minority stake in Regulus Therapeutics Inc.

Officers and directors

Serge Weinberg Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Christopher A. Viehbacher Chief Executive Officer, Chairman of the Executive Committee and Global Leadership Team and Director
Age: 54
Bio & Compensation  - Reuters
Jerome Contamine Executive Vice President - Chief Financial Officer, Member of the Executive Committee and Global Leadership Team
Age: 56
Bio & Compensation  - Reuters
Peter Guenter Executive Vice President - Global Commercial Operations, Member of the Executive Committee and the Global Leadership Team
Bio & Compensation  - Reuters
David P. Meeker M.D. Member of the Executive Board and Executive Vice President - Genzyme and Member of the Global Leadership Team
Bio & Compensation  - Reuters
Pascale Witz Executive Vice President - Global Divisions & Strategic Commercial Development, Member of the Executive Committee and the Global Leadership Team
Bio & Compensation  - Reuters
Carsten Hellmann Executive Vice President - Animal Health and Member of the Global Leadership Team
Age: 49
Bio & Compensation  - Reuters
Karen Linehan Member of the Executive Board, Member of the Management Board, Senior Vice President, General Counsel
Age: 55
Bio & Compensation  - Reuters
Roberto Pucci Senior Vice President - Human Resources, Member of the Executive Committee and the Global Leadership Team
Age: 50
Bio & Compensation  - Reuters
Olivier Charmeil Senior Vice President - Vaccines, Member of the Executive Committee and Global Leadership Team
Age: 51
Bio & Compensation  - Reuters